CLINICAL_TRIALS
trial_result
· 2018-06-13
Clinical Trial Update: Safety and Pharmacokinetics Study of Anthrax Immune Globulin Intravenous (AIGIV) [Phase 1, Phase 2]
Summary
Phase 1/2 safety and pharmacokinetics study of Anthrax Immune Globulin Intravenous (AIGIV) has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Emergent BioSolutions | Conditions: Anthrax | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-06-13